The Latest
Are Monoclonal Antibodies the Future of COVID-19 Treatment?
Infectious-diseases researcher David Wohl, M.D., talks about a major COVID-19 treatment trial in the works—and how it relates to our efforts against HIV.
This Week in HIV Research: The Long Road to Racial Health Justice
Sept. 24, 2020: HIV adherence cohorts usually fail to reflect the diversity of the epidemic; HIV thrives in deprived neighborhoods; rethinking barriers to rapid HIV treatment initiation; long-term adverse events on INSTIs vs. efavirenz.
Immediate HIV Treatment Initiation With Integrase Inhibitors Leads to Large Drop in Secondary HIV Transmission Among MSM
Integrase inhibitors are known to be potent first-line therapy options. Recent research suggests their benefits extend to onward HIV prevention as well.
This Week in HIV Research: Disclosing Our Disparities
Sept. 17, 2020: HIV prevalence gaps between Latinx people and non-Latinx white people; Obamacare awareness and perceptions among HIV clinicians; the relationship between pain and HIV; cancer mortality trends among PLWH.
Real Talk at SYNChronicity 2020: Black Women Are Essential to Eliminating HIV
Open conversations between care providers and Black women are vitally important in order to empower women with information about HIV and how to protect their health.
This Week in HIV Research: Where the Rubber Meets the Ring
Sept. 10, 2020: Concomitant use of vaginal rings with condoms; benefits of more frequent HIV screening for young MSM; Black MSM, substance use, and the PrEP continuum; HIV outcomes stratified by anti-LGTBQ policy across U.S. states.
Remembering Peter Stinner, a Keystone of Atlanta’s HIV Community
Stinner's husband, Jeff Graham, and colleague, Jonathan Colasanti, M.D., share a trove of stories about a person who embodied the ideals of empathy and care in HIV and health services.
This Week in HIV Research: Hep C, That Other Epidemic Within an Epidemic
Sept. 3, 2020: A hepatitis C microelimination program for people living with HIV; PrEP concentrations and gender-affirming hormones; a collaborative intervention to improve opioid prescribing practices; TDF and fracture risk.
Getting PrEP to Those Who Need It During COVID-19 Has Presented New Challenges
Washington, D.C. area community organizations and clinics have moved a lot of prevention efforts online, but much is missing without in-person contact.
This Week in HIV Research: When Treating Trans Patients, Check Your Priors
Aug. 27, 2020: Traditional CVD risk calculation tools falter for transgender women; switching to B/F/TAF despite NRTI resistance; how tenofovir has altered the HBV landscape; syndemic effects on viral load and blood pressure.